Achieve Life Sciences, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Achieve Life Sciences, Inc.
Artificial intelligence (AI) vendors are partnering with health care providers to identify practical challenges and consider AI technology as a potential solution. This type of collaboration is crucial to successful AI adoption because the technology is designed to tackle real-world health care problems. A myriad of examples was displayed at the recent RSNA 2020 meeting.
Although SRF813 isn’t likely to reach the clinic until 2021, GSK likes cell therapy’s monotherapy and combination potential. Lilly bids $880m to acquire neurodegenerative cell therapy firm Prevail.
The $250m deal adds A&E Medical’s sternal sutures, cable systems, and rigid fixation systems to Zimmer Biomet’s Dental, Spine & Craniomaxillofacial and Thoracic business.
Orthopedic implant company Arthrosurface is hoping to get hand surgeons' attention with its new allograft thumb implant to treat osteoarthritis.
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- OncoGenex Pharmaceuticals, Inc.
- Sonus Pharmaceuticals, Inc.